Search

everythinglearnresearchcommunity

for

Search:↓

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Testosterone increases hair growth and acne in transgender men.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Altering maternal cortisol during pregnancy can improve wool growth in Merino sheep.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Dimethyl-fumarate may cause temporary hair loss.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Proteolytic enzymes damage hair follicles by detaching stem cells.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

Genetically modified sheep with more β-catenin grew more wool without changing the wool's length or thickness.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Malnutrition can cause unusual eyelash growth and hair loss.

Plasmalogens activate a channel in cells that may stimulate hair growth.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Mice with human chymase had a higher death rate when exposed to a toxin compared to normal mice.

Scientists made a mouse that can be made to lose hair and then grow it back.

The E2 protein affects gene activity in hair follicles of mice.

Overexpressing ovine β-catenin in mice skin increases hair follicle density and growth.

BST2 protein and certain T cells increase in early alopecia areata.

Proteolytic enzymes damaged hair follicle stem cells in transgenic mice.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

A baby boy had two types of temporary hair loss at birth, which might be two forms of newborn hair loss combined.

Many transgender men on testosterone therapy experience hair loss.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.